Skip to content

Pain management in rheumatoid arthritis.

An open label randomized clinical trial to evaluate the add on effects of deepana - pachana yoga in the management of Naveen avastha of amavata with special reference to rheumatoid arthritis.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024778
Enrollment
60
Registered
2020-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement

Interventions

Intervention1: Vaishwanar churna Panchkola sadhit yavagu Haritaki churna Shunthi sadhit jala: 1. Vaishwanar churna 3gm OD empty stomach with lukewarm water 2. Panchkola sadhit yavagu 200-300ml BD 3. H

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with pratyatma lakshana of Amavata (e.g. Angamarda, shotha, sandhishool, stabhata, Trishna, Alasye, Aruchi, gaurava, jawara, apaka sparshaasahata) specially with impaired jatharagani and dhatuagani. 2. The 2010 American College of Rheumtology/ European League Against Rheumatism. 3. Able and willing to give written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with other systemic complications of RA like RHD, Rheumatic fever, pleural â??pericardial disease. 2. Patients with poorly controlled Hypertension ( >160/100 mm of Hg). 3. Patients with Diabetes Mellitus {B.S. (F) > 126 mg% and / or B.S. (2 hr. PP) >200 mg% OR HbA1c > 6.5%} 4. Patients diagnosed with other arthritis like gouty arthritis, tuberculous arthritis etc. 5. Patients who are unable to walk without support and / or confined to wheel chair. 6. Patients on prolonged medication with NSAIDs, analgesics or any other drugs that may have an influence on the outcome of the study. 7. Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months. 8. Patients with concurrent serious hepatic disorder or Renal Disorders. Severe Pulmonary Dysfunction or any other condition that may jeopardize the study. 9. H/o hypersensitivity to any of the trial drugs or their ingredients. 10. Pregnant / lactating woman. 11. Patients who have completed participation in any other clinical trial during the past 6 months.

Design outcomes

Primary

MeasureTime frame
1. Relieve in the impaired jatharagani and dhatuagani. 2. Relieve in signs and symptoms of amavata.Timepoint: 37-40 days

Secondary

MeasureTime frame
Improvement in the quality of life with the help of questionnaires for scaling of W.H.O quality of life. Timepoint: 37-40 days

Countries

India

Contacts

Public ContactDr Shimmi

All India Institute of Ayurveda

drvghuddar@gmail.com9986697942

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026